Key Highlights
•
Researchers have identified a protein called Mettl8 that acts like a “brake,” preventing exhausted immune cells from maturing into effective cancer fighters. Blocking Mettl8 allows these cells to become more powerful, offering a promising new way to boost the effectiveness of existing cancer immunotherapies.
Source →
•
In mouse studies, deleting the Mettl8 protein helped control tumor growth by pushing “stem-like” exhausted T cells to develop into a more potent, intermediate state. This finding is crucial because it reveals a specific molecular target that could be used in combination with drugs like anti-PD-1 to create more powerful and synergistic cancer treatments.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
